Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-010020
Filing Date
2025-12-09
Accepted
2025-12-09 17:12:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3327
  Complete submission text file 0001950047-25-010020.txt   4925
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-31812 | Film No.: 251559946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9220 KIRBY DRIVE SUITE 500 HOUSTON TX 77054
Business Address
TANNENBAUM RENEE P (Reporting) CIK: 0001543174 (see all company filings)

Type: 144